Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The goal of this review was to assess the effectiveness of ketogenic diets on the therapy of neurodegenerative diseases. The ketogenic diet is a low-carbohydrate and fat-rich diet. Its implementation has a fasting-like effect, which brings the body into a state of ketosis. The ketogenic diet has, for almost 100 years, been used in the therapy of drug-resistant epilepsy, but current studies indicate possible neuroprotective effects. Thus far, only a few studies have evaluated the role of the ketogenic diet in the prevention of Parkinson’s disease (PD) and Alzheimer’s disease (AD). Single studies with human participants have demonstrated a reduction of disease symptoms after application. The application of the ketogenic diet to elderly people, however, raises certain concerns. Persons with neurodegenerative diseases are at risk of malnutrition, while food intake reduction is associated with disease symptoms. In turn, the ketogenic diet leads to a reduced appetite; it is not attractive from an organoleptic point of view, and may be accompanied by side effects of the gastrointestinal system. All this may lead to further lowering of consumed food portions by elderly persons with neurodegenerative diseases and, in consequence, to further reduction in the supply of nutrients provided by the diet. Neither data on the long-term application of the ketogenic diet in patients with neurodegenerative disease or data on its effects on disease symptoms are available. Further research is needed to evaluate the suitability of the ketogenic diet in the therapy of AD- or PD-affected persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the neuroprotective effects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
In the citing paper
“Włodarek et al. (106) found that a ketogenic diet, which is high in fat, moderate in protein, and low in carbohydrates, has the potential to reduce neuronal degeneration, and that this specific type of nutritional intervention may provide neuroprotection.”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tranfield, D., Denyer, D., & Smart, P. (2003) · British Journal of Management · doi:10.1111/1467-8551.00375 · Cited by 15,386 · cited 1×
“The literature’s analyses on the ketogenic diet in the context of neurodegenerative diseases was based on the principles of a structured literature review, a tool used in developing evidence-based knowledge in a rigorous and relevant way [17].”
MethodBauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · cited 1×
“2 g of protein/kg per day, or even more if they are physically active [57].”
BackgroundJasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885 · cited 1×
“In consequence, there is an increased secretion of metabolism nitrogen products, so diuresis in enhanced to maintain a constant dilution of these metabolites in urine [55], while in persons with normal kidney function, it need not exert any negative effects on the body [55].”
BackgroundClinical definition of sarcopenia
Santilli, V (2014) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2014.11.3.177 · Cited by 710 · cited 1×
“Sarcopenia is a problem which affects elderly persons, and its incidence increases with age [56].”
BackgroundThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574 · cited 1×
“Caloric restriction also has anti-inflammatory effects; it can reduce levels of NFkB, the central component of the inflammatory process, and block the synthesis of interleukins (IL1β, IL2, IL4, IL6) and tumor necrosis factors (TNFα) and suppresses the activity of cyclooxygenase-2 (COX-2) and inducible nitric oxide syn…”
BackgroundHenderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · cited 2×
“A diet based on medium-chain triglycerides (MCT) was applied as a form of therapy in the 1950s [11], which led to an increase in the concentration of ketone bodies in the blood, even if carbohydrates were present in the diet; thus, this version of KD enables the production of ketone bodies without drastic changes in d…”
d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 535 · cited 2×
“It was shown that beta-hydroxybutyrate acts in vitro as a neuroprotective agent against the toxicity of MPTP on dopaminergic neurons [7].”
BackgroundManoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523 · cited 1×
“Imbalance in dopamine metabolism due to oxidative stress has been recognized as a contributor to this disease [21].”
BackgroundEffects of β-hydroxybutyrate on cognition in memory-impaired adults
Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 508
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease
Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318797 · Cited by 497 · cited 1×
“[43] concluded that in mice administered with the MPTP neurotoxin, which induces a defect of the mitochondrial complex I, an administration of beta-hydroxylactate reduced the neurotoxicity of the compound via effects exerted on complex II and by improvement of cellular respiration and ATP production.”
BackgroundNeuroprotective and disease-modifying effects of the ketogenic diet
Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445 · cited 3×
“A diet based on medium-chain triglycerides (MCT) was applied as a form of therapy in the 1950s [11], which led to an increase in the concentration of ketone bodies in the blood, even if carbohydrates were present in the diet; thus, this version of KD enables the production of ketone bodies without drastic changes in d…”
MethodResultThe Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders
Stafstrom, C. E., & Rho, J. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00059 · Cited by 438 · cited 1×
“Although the direct link between caloric restriction and KD mechanisms raises certain controversies, both treatments result in a reduction of the blood glucose concentration, likely involving reduced glycolytic flux [24].”
BackgroundKashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363 · cited 1×
“It was also observed that a long-term administration of ketone body esters to mice improved their cognitive functions and reduced beta-amyloid and highly phosphorylated tau proteins in the brain [30].”
BackgroundDietary ketosis enhances memory in mild cognitive impairment
Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.006 · Cited by 361
Ketogenic Diet for Obesity: Friend or Foe?
Paoli, A. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110202092 · Cited by 352
van Gelder, B. M., Tijhuis, M., Kalmijn, S., & Kromhout, D. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.4.1142 · Cited by 346
Clarke, K., Tchabanenko, K., Pawlosky, R., Carter, E., Todd King, M., Musa-Veloso, K., Ho, M., Roberts, A., Robertson, J., VanItallie, T. B., et al. (2012) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2012.04.008 · Cited by 332 · cited 2×
“Some studies suggest that an exogenous ketone supply increases the level of ketone bodies in serum [14,15].”
BackgroundMethodA ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
Van der Auwera, I., Wera, S., Van Leuven, F., & Henderson, S. T. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-28 · Cited by 307
Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study
VanItallie, T. B., Nonas, C., Di Rocco, A., Boyar, K., Hyams, K., & Heymsfield, S. B. (2005) · Neurology · doi:10.1212/01.wnl.0000152046.11390.45 · Cited by 300 · cited 1×
“[51] observed 5 patients with PD who had agreed to adhere to KD rules in their home environments.”
BackgroundKetogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice
Ma, D., Wang, A. C., Parikh, I., Green, S. J., Hoffman, J. D., Chlipala, G., Murphy, M. P., Sokola, B. S., Bauer, B., Hartz, A. M. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25190-5 · Cited by 299 · cited 1×
“[33] investigated the influence of the ketogenic diet on the neurovascular function and alteration of gut microbiomes in young healthy mice.”
BackgroundLow-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial
Phillips, M. C. L., Murtagh, D. K. J., Gilbertson, L. J., Asztely, F. J. S., & Lynch, C. D. P. (2018) · Movement Disorders · doi:10.1002/mds.27390 · Cited by 292
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhao, Z., Lange, D. J., Voustianiouk, A., MacGrogan, D., Ho, L., Suh, J., Humala, N., Thiyagarajan, M., Wang, J., & Pasinetti, G. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-29 · Cited by 286 · cited 1×
“The ketogenic diet (KD) was first used in order to reduce the incidence of epileptic seizures [1,2] and, over time, its application in other diseases was studied, including such medical conditions as amyotrophic lateral sclerosis (Charcot’s disease) [3,4], traumatic brain injury [5], cerebral ischemia [6], and neurode…”
BackgroundOta, M., Matsuo, J., Ishida, I., Takano, H., Yokoi, Y., Hori, H., Yoshida, S., Ashida, K., Nakamura, K., Takahashi, T., et al. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.048 · Cited by 276 · cited 1×
“[36] administrated medium-chain triglycerides to 20 Japanese patients with mild-to-moderate AD on separate days (50 g of a ketogenic formula containing 20 g of MCTs or an isocaloric placebo formula without MCTs).”
BackgroundFeasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
Taylor, M. K., Sullivan, D. K., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.11.002 · Cited by 272 · cited 1×
“In the Ketogenic Diet Retention and Feasibility Trial [37], 15 patients with AD maintained an MCT-supplemented KD (approximately 70% of energy as fat, including the MCT; 20% energy as protein; and less than 10% of energy as carbohydrates).”
BackgroundKetosis, ketogenic diet and food intake control: a complex relationship
Paoli, A., Bosco, G., Camporesi, E. M., & Mangar, D. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00027 · Cited by 259 · cited 1×
“However, the net balance between contrasting stimuli cause a loss of appetite and, in consequence, reduced food intake [54].”
BackgroundThe regulation of the release of ketone bodies by the liver
Krebs, H. A. (1966) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(66)90027-6 · Cited by 259 · cited 1×
“It was first referred to by Hans Krebs as “physiological ketosis” to differentiate it from the pathological ketoacidosis seen in the diabetes type 1 [20].”
BackgroundSolfrizzi, V., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Rizzo, C., Capurso, A., & Panza, F. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.026 · Cited by 257
Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases
Paoli, A., Bianco, A., Damiani, E., & Bosco, G. (2014) · BioMed Research International · doi:10.1155/2014/474296 · Cited by 220 · cited 1×
“The process of their production is called ketogenesis, and occurs mainly in the mitochondrial matrix of hepatic cells [18].”
BackgroundSaturated and trans fats and dementia: a systematic review
Barnard, N. D., Bunner, A. E., & Agarwal, U. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.030 · Cited by 172 · cited 1×
“Epidemiological studies demonstrate that a diet rich in saturated fatty acids increases the risk of AD [26].”
BackgroundNovel ketone diet enhances physical and cognitive performance
Murray, A. J., Knight, N. S., Cole, M. A., Cochlin, L. E., Carter, E., Tchabanenko, K., Pichulik, T., Gulston, M. K., Atherton, H. J., Schroeder, M. A., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600773r · Cited by 165
Suzuki, M., Suzuki, M., Sato, K., Dohi, S., Sato, T., Matsuura, A., & Hiraide, A. (2001) · Japanese Journal of Pharmacology · doi:10.1254/jjp.87.143 · Cited by 160
Neuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity
Yang, X., & Cheng, B. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9336-y · Cited by 158 · cited 1×
“In other studies, the beneficial effects of ketone bodies were described, resulting from a mitigated inflammatory condition induced by MPTP administration [48] and from reduced apoptosis of dopaminergic cells exposed to substances causing their death [49].”
BackgroundKetogenic Diet Increases Glutathione Peroxidase Activity in Rat Hippocampus
Ziegler, D. R., Ribeiro, L. C., Hagenn, M., Siqueira, L., de Araújo, E. M., Torres, I. L. D. S., Gottfried, C., Netto, C. A., & Gonçalves, C. (2003) · Neurochemical Research · doi:10.1023/a:1026107405399 · Cited by 153 · cited 1×
“It is suggested that the higher activity of this enzyme, induced by the ketogenic diet in the hippocampus, might contribute to the protection of this structure from neurodegenerative changes [23].”
BackgroundBrownlow, M. L., Benner, L., D’Agostino, D., Gordon, M. N., & Morgan, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075713 · Cited by 153 · cited 1×
“The benefits of the KD was also proven with regard to the motor functions of the experimental animals, with no effect on either amyloid-beta or protein tau deposits [31,32].”
BackgroundKetogenic diets: new advances for metabolism-based therapies
Kossoff, E. H., & Hartman, A. L. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283515e4a · Cited by 135
Sah, S. K., Lee, C. M., Jang, J., & Park, G. H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.122 · Cited by 135 · cited 1×
“What is more, a fat-rich diet, applied in transgenic mice, may accelerate cognitive impairment by promoting systemic inflammation, enhancing oxidative stress, and aggravating neuronal apoptosis [27,28].”
BackgroundCavaleri, F., & Bashar, E. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/7195760 · Cited by 126 · cited 1×
“Various ketone sources exist naturally in food; dairy products are a natural source of β-hydroxybutyrate [13].”
BackgroundHigh fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice
Thériault, P., ElAli, A., & Rivest, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12179 · Cited by 121 · cited 1×
“What is more, a fat-rich diet, applied in transgenic mice, may accelerate cognitive impairment by promoting systemic inflammation, enhancing oxidative stress, and aggravating neuronal apoptosis [27,28].”
BackgroundKetones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors
Kim, D. Y., Vallejo, J., & Rho, J. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06728.x · Cited by 113
Cheng, B., Yang, X., An, L., Gao, B., Liu, X., & Liu, S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.060 · Cited by 113 · cited 1×
“[50] concluded that KD, via glutathione activity, exerted a neuroprotective effect against the toxic effect of 6-hydroxydopamine.”
BackgroundThe collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury
Prins, M. L., & Matsumoto, J. H. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046706 · Cited by 107 · cited 1×
“The ketogenic diet (KD) was first used in order to reduce the incidence of epileptic seizures [1,2] and, over time, its application in other diseases was studied, including such medical conditions as amyotrophic lateral sclerosis (Charcot’s disease) [3,4], traumatic brain injury [5], cerebral ischemia [6], and neurode…”
BackgroundLopez, L. B., Kritz-Silverstein, D., & Barrett-Connor, E. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0009-5 · Cited by 101
Tefera, T. W., & Borges, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00611 · Cited by 100 · cited 1×
“The ketogenic diet (KD) was first used in order to reduce the incidence of epileptic seizures [1,2] and, over time, its application in other diseases was studied, including such medical conditions as amyotrophic lateral sclerosis (Charcot’s disease) [3,4], traumatic brain injury [5], cerebral ischemia [6], and neurode…”
BackgroundThe Expanding Role of Ketogenic Diets in Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Brain Sciences · doi:10.3390/brainsci8080148 · Cited by 98
Beckett, T. L., Studzinski, C. M., Keller, J. N., Paul Murphy, M., & Niedowicz, D. M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.046 · Cited by 94 · cited 1×
“The benefits of the KD was also proven with regard to the motor functions of the experimental animals, with no effect on either amyloid-beta or protein tau deposits [31,32].”
BackgroundStudzinski, C. M., MacKay, W. A., Beckett, T. L., Henderson, S. T., Murphy, M. P., Sullivan, P. G., & Burnham, W. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.005 · Cited by 93 · cited 1×
“[34], in their studies on senile dogs, demonstrated that a diet with MCTs improved mitochondrial function by control of the oxidation process.”
BackgroundKetones Prevent Oxidative Impairment of Hippocampal Synaptic Integrity through KATP Channels
Kim, D. Y., Abdelwahab, M. G., Lee, S. H., O’Neill, D., Thompson, R. J., Duff, H. J., Sullivan, P. G., & Rho, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119316 · Cited by 77
The efficacy of the ketogenic diet on motor functions in Parkinson's disease: A rat model.
Shaafi, S., Najmi, S., Aliasgharpour, H., Mahmoudi, J., Sadigh-Etemad, S., Farhoudi, M., & Baniasadi, N. (2016) · PubMed Central · Cited by 74
Cheng, B., Yang, X., Hou, Z., Lin, X., Meng, H., Li, Z., & Liu, S. (2007) · Autonomic Neuroscience · doi:10.1016/j.autneu.2007.02.002 · Cited by 37
Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease
Joniec‐Maciejak, I., Wawer, A., Turzyńska, D., Sobolewska, A., Maciejak, P., Szyndler, J., Mirowska-Guzel, D. M., & Płaźnik, A. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.04.008 · Cited by 34 · cited 1×
“[45] examined the possible protective effects of octanoic acid in the mouse model of PD induced by MPTP.”
BackgroundConcomitant meal ingestion alters levels of circulating ketone bodies following a ketone ester drink
Stubbs, B., Willerton, K., Hiyama, S., Clarke, K., & COX, P. J. (2015) · Proceedings of The Physiological Society · Cited by 9
[Anticonvulsant and neuroprotective effects of the ketogenic diet].
Chorągiewicz, T., Żarnowska, I., Ga̧sior, M., & Żarnowski, T. (2010) · PubMed · Cited by 8
Research works printed but not linked: 4
- Conklin, 1922, Cause and treatment of epilepsy, Jam. Osteopatic. Assoc., 26, 11
- Guelpa, 1911, A lutte contre l’epilepsie par la desintoxication et par la reduction altimentaire, Rev. Ther. Med. Chir. (Paris), 78, 8
- 2012, Characteristisc of ketogenic diet and its terapeutic properties in central nevous system disorders, Annal Academiae Medicea Silesiensis, 66, 66
- Nazarewicz, 2007, Effects of high fat ketogenic diets, Bromat. Chem. Toksykol., XL, 371
Cited by
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
“However, KD application for the elderly arouses concerns since people with neurodegenerative diseases have risks of malnutrition and KD might lead to a reduced appetite and be accompanied by gastrointestinal side effects, exacerbating any nutritional deficits [90].”
BackgroundEffects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
Ketogenic Diet in Alzheimer’s Disease
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163892 · Cited by 319
Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
Phillips, M. C. L., Deprez, L. M., Mortimer, G. M. N., Murtagh, D. K. J., McCoy, S., Mylchreest, R., Gilbertson, L. J., Clark, K. M., Simpson, P. V., McManus, E. J., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00783-x · Cited by 249
“This proportion is also high given that ketogenic diets are often considered unpalatable [25].”
BackgroundThe Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215
Metadata
- Authors
- Włodarek, D.
- Affiliations
- Warsaw University of Life Sciences (PL)
- Corresponding author
- Włodarek, Dariusz
- ORCID
- Włodarek, Dariusz
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-01-15
- Volume
- 11
- Issue
- 1
- Pages
- 169
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356942
- OpenAlex
- W2910859275
- Semantic Scholar
- 7d537ea1be5b6de5ff1d316704c5f868eee0291a
- Cited by
- 301
- References
- 53
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 39 · 2023: 46 · 2022: 55 · 2021: 52 · 2020: 40 · 2019: 17
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- ketogenic diet, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, ketosis, neuroprotection, drug-resistant epilepsy, malnutrition, appetite suppression, gastrointestinal adverse effects, elderly patients, hypophagia
- MeSH terms
- Alzheimer Disease, Appetite, Brain, Feeding Behavior, Humans, Ketosis, Nutritional Status, Parkinson Disease, Malnutrition, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.